CGM vs. Finger-Stick Testing: Is the Cost Worth It?

What Was Studied and Why It Matters

Keeping blood sugar under control is one of the most important jobs for anyone living with type 2 diabetes. Two main tools exist to do that: the traditional finger-stick method called self-monitoring of blood glucose (SMBG), and a newer technology called continuous glucose monitoring (CGM), which tracks blood sugar automatically throughout the day and night.

CGM devices have become increasingly popular, but they cost significantly more than standard glucose meters and test strips. Researchers in Iran wanted to find out whether that extra cost is actually worth it — a question that matters to patients, caregivers, insurers, and health systems around the world.

What the Researchers Did

The research team ran a detailed economic analysis comparing CGM to finger-stick testing over a patient's entire lifetime. They used a well-respected diabetes outcomes model (called the UKPDS Outcomes Model) and plugged in real clinical data from Iranian patients with type 2 diabetes. Their goal was to calculate what is known as an incremental cost-effectiveness ratio (ICER) — essentially, how much extra money it costs to gain one additional year of healthy life by choosing CGM over standard testing.

What They Found

The results were striking. Choosing CGM over finger-stick testing cost an additional $40,444 over a lifetime, while providing only a modest improvement in quality-adjusted life — roughly 35 extra days of healthy living. That works out to a cost of nearly $398,000 per quality year of life gained, which is far above what most health systems consider affordable or worthwhile.

• CGM provided a small but real improvement in health outcomes
• The extra cost, however, was very high relative to that benefit
• Even running the numbers 100 different ways, CGM was not considered cost-effective in any scenario

What This Means for Real Patients

This study was conducted in Iran, where healthcare budgets and pricing structures differ from countries like the United States, Canada, or the UK. So the exact dollar figures may not apply directly to your situation. However, the core message is important everywhere: CGM is a powerful tool, but it carries a real price tag.

For patients who struggle with hypoglycemia (dangerous low blood sugar), use insulin, or have difficulty with frequent finger-sticks, CGM may still be the right choice based on individual health needs — and your doctor is the best person to make that call with you.

For many people with type 2 diabetes managing with oral medications, consistent finger-stick testing using quality supplies remains a reliable and affordable option. MDS Diabetes offers a wide range of glucose meters, test strips, and lancets to support your daily monitoring routine without breaking the bank.

Bottom Line

A new study found that continuous glucose monitors provide only modest health benefits over traditional finger-stick testing in type 2 diabetes — but at a dramatically higher cost. While CGM technology continues to improve, standard blood glucose monitoring with dependable supplies from a trusted source like MDS Diabetes remains a smart, effective choice for many patients. Always talk to your healthcare provider about which monitoring method fits your health needs and budget best.